CIK: 1607733 - Address: C/o Theravance Biopharma Us, Inc., 901 Gateway Blvd, South San Francisco, CA 94080
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret113-01249908
S%wins1003300027

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/24/20 18:21
8/21/20
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsHaumann Brett KCAOChief MeS-45718.290-25-8283D
3/8/17 18:11
3/6/17
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsHaumann Brett KCAOSVP ClinS.m-44131.507-14-8163D5168665-60-30-215
8/25/16 19:34
8/25/16
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsHaumann Brett KCAOSVP ClinS-12627.996-4-2188D-412971251914-1-1012838
8/23/16 19:23
8/19/16
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsHaumann Brett KCAOSVP ClinS-26627.976-10-5193D-3106893013-14-3-13281510

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact